This isn’t the first pandemic humanity has faced. From the black death to Spanish flu, from AIDS to Ebola; we’ve been here before.
The hunt to find antiviral drugs has pressed on as we await a vaccine.
How do you measure immunity with the novel coronavirus?
African Americans are dying at higher rates despite only being a segment of the population.
Queensland University of Technology mental health researcher Dr Olivia Fisher explains what’s really driving the anxiety we’re feeling through the pandemic, and how to respond to it.
As an expert on the fluid dynamics of disease, MIT associate professor Lydia Bourouiba discusses the implications of airborne transmission.
Until we can immunize against it, we need alternatives to fight the virus: drugs and therapies. President of global immunization at the Sabin Vaccine Institute, Dr Bruce Gellin, walks us through it all.
Bio-statistician Adam Kucharski joins Bill Nye to make sense of the data on COVID-19, and what to watch out for.
The Coronasode we’ve been waiting for! Vaccines. Finally. But what does this mean?
Scientists are still trying to understand the many ways COVID-19 can damage the brain.
The the Pfizer-BioNTech vaccine is the first widely-available vaccine to use something called mRNA technology.
The FDA has given emergency use authorization to two monoclonal antibody treatments for COVID-19 – bamlanivimab, produced by Eli Lilly, and a two-antibody combination developed by Regeneron.